Annual report [Section 13 and 15(d), not S-K Item 405]

Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Dare (Details)

v3.25.1
Royalty and Commercial Payment Purchase Agreements - Cost Recovery Method - Dare (Details) - USD ($)
$ in Thousands
 12 Months Ended
Apr. 29, 2024
Dec. 31, 2024
Dec. 31, 2023
Agreements      
Payments of consideration under RPAs, AAAs and CPPAs   $ 53,000 $ 14,650
Short-term royalty and commercial payment receivables under the cost recovery method   413 $ 14,215
Royalty Purchase Agreement | Dare      
Agreements      
Payments of consideration under RPAs, AAAs and CPPAs $ 22,000    
Percentage of remaining royalties 100.00%    
Payable on milestone $ 11,000    
Specified amount of each successive receipt that requires milestone payment 22,000    
Return threshold $ 88,000    
Short-term royalty and commercial payment receivables under the cost recovery method   0  
Allowance for credit losses   $ 0  
Royalty Purchase Agreement | Dare | OVAPRENE      
Agreements      
Royalties entity has right to receive (as a percent) 4.00%    
Royalty Purchase Agreement | Dare | OVAPRENE | Upon achievement of a pre-specified return threshold      
Agreements      
Royalties entity has right to receive (as a percent) 2.50%    
Royalty Purchase Agreement | Dare | Sildenafil Cream      
Agreements      
Royalties entity has right to receive (as a percent) 2.00%    
Royalty Purchase Agreement | Dare | Sildenafil Cream | Upon achievement of a pre-specified return threshold      
Agreements      
Royalties entity has right to receive (as a percent) 1.25%